1990
DOI: 10.1016/0268-9499(90)90157-f
|View full text |Cite
|
Sign up to set email alerts
|

Plasminogen activator inhibitor 2: a new plasma and cellular marker for leukemias with a monocytic component

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
1995
1995

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In support of the role of PAI-2 in cell death, PAI-2 is expressed in vivo in skin (65) in a zone associated with keratinocyte differentiation and apoptosis. Tumor cells have also been found to synthesize PAI-2 (66,67), and transformation by ras and src oncogenes has been shown to induce PAI-2 expression in vitro (68). Given the effect of PAI-2 on cell survival, acquisition of PAI-2 expression by tumor cells may reduce their susceptibility to TNF-mediated apoptosis and thereby allow a selective survival advantage to these tumor cells.…”
Section: Discussionmentioning
confidence: 99%
“…In support of the role of PAI-2 in cell death, PAI-2 is expressed in vivo in skin (65) in a zone associated with keratinocyte differentiation and apoptosis. Tumor cells have also been found to synthesize PAI-2 (66,67), and transformation by ras and src oncogenes has been shown to induce PAI-2 expression in vitro (68). Given the effect of PAI-2 on cell survival, acquisition of PAI-2 expression by tumor cells may reduce their susceptibility to TNF-mediated apoptosis and thereby allow a selective survival advantage to these tumor cells.…”
Section: Discussionmentioning
confidence: 99%